Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conference.
Share this article
Corporate
Score 65
Bullish
Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conference
Mar 15, 2026 23:32 UTC
EVL, BOTO, XLV
Long term
Related Articles
Score 65
Bullish
Goodbye, Grunt Work: Oracle's AI Just Reclaimed 200,000 Hours For Doctors
Mar 15, 23:30
Score 65
Bullish
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment
Mar 15, 23:25
Score 85
Bullish
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
Mar 15, 23:17
Score 35
This Community Bank With $9 Billion in Assets Just Drew a $2.5 Million Investor Buy
Mar 15, 22:46
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.